The limitations of our study included the lack of molecular-based analysis of the direct link between CCNDBP1 and EZH2 and of human HCC samples to enable application of the results to radiotherapy and chemotherapy resistance. The gene discussed is EZH2; the disease is hepatocellular carcinoma.